Keywords: تولوترودین; Mirabegron; Tolterodine; Drug-drug interaction; Pharmacokinetics and drug metabolism; Overactive bladder; Japanese;
مقالات ISI تولوترودین (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: تولوترودین; Overactive bladder; Tolterodine; Vaginal cone; Efficacy; Pelvic floor exercise
Keywords: تولوترودین; Tolterodine; Hydrogels; Pharamcokinetics; Box-Behnken design; Film-forming;
Keywords: تولوترودین; Tolterodine; Methyl orange; Extractive colorimetric; Solid dosage;
Effect of 22 CYP2D6 variants found in the Chinese population on tolterodine metabolism in vitro
Keywords: تولوترودین; CYP2D6; Allelic variants; Tolterodine; Drug metabolism; In vitro;
Clinical and urodynamic effects of tolterodine in women with an overactive bladder
Keywords: تولوترودین; overactive bladder; tolterodine; urodynamic study
Preparation, characterization and pharmacological evaluation of tolterodine hydrogels for the treatment of overactive bladder
Keywords: تولوترودین; Tolterodine; Hydrogels; Transdermal; Pharmacokinetics; Pharmacodynamics
Randomized Double-blind, Active-controlled Phase 3 Study to Assess 12-Month Safety and Efficacy of Mirabegron, a β3-Adrenoceptor Agonist, in Overactive Bladder
Keywords: تولوترودین; Mirabegron; Tolterodine; Overactive bladder
Traitements pharmacologiques de l’hyperactivité vésicale idiopathique : revue de la littérature
Keywords: تولوترودین; Hyperactivité vésicale idiopathique; Anticholinergiques; Fésotérodine; Toltérodine; Trospium; Solifénacine; OxybutinineOveractive bladder; Idiopathic; Antimuscarinics; Fesoterodine; Tolterodine; Solifenacin; Trospium chloride; Oxybutinin
A validated LC–MS/MS method for the determination of tolterodine and its metabolite in rat plasma and application to pharmacokinetic study
Keywords: تولوترودین; LC–MS/MS; Tolterodine; 5-Hydroxy methyl tolterodine; Pharmacokinetics
A retrospective observational study of enuresis, daytime voiding symptoms, and response to medical therapy in children with attention deficit hyperactivity disorder and autism spectrum disorder
Keywords: تولوترودین; Enuresis; Voiding dysfunction; Autism; Asperger; Pervasive developmental disorder; Desmopressin; DDAVP; Anticholinergic; Oxybutynin; Tolterodine
Cost-Effectiveness of Percutaneous Tibial Nerve Stimulation Versus Extended Release Tolterodine for Overactive Bladder
Keywords: تولوترودین; cost-benefit analysis; tolterodine; tibial nerve; urinary incontinence; urge; urinary bladder; overactive; E&M; Evaluation and Management; ICER; incremental cost-effectiveness ratio; OAB; overactive bladder; PTNS; percutaneous tibial nerve stimulation; QA
Potentiometric determination of tolterodine in batch and flow injection conditions
Keywords: تولوترودین; FIA; Pharmaceutical analysis; Tolterodine; Biological samples; Potentiometry;
Prospective Open Label Study of Solifenacin for Overactive Bladder in Children
Keywords: تولوترودین; urinary bladder; overactive; cholinergic antagonists; oxybutynin; tolterodine; urination disorders; ER; extended release; HRQL; health related quality of life; IR; immediate release; OAB; overactive bladder; PPBC; patient perception of bladder condition;
Studies on the preparation, characterization and pharmacological evaluation of tolterodine PLGA microspheres
Keywords: تولوترودین; PLGA; Tolterodine; Pharmacokinetics; Pharmacodynamics; Microspheres
A Multicenter, Double-Blind, Randomized, Placebo Controlled Trial of a Neurokinin-1 Receptor Antagonist for Overactive Bladder
Keywords: تولوترودین; receptors; neurokinin-1; tolterodine; muscarinic antagonists; urinary bladder; overactiveAE, adverse experience; ER, extended release; LS, least squares; NK-1R, neurokinin-1 receptor; OAB, overactive bladder; SP, substance P; TKs, tachykinins
Randomized Trial of Percutaneous Tibial Nerve Stimulation Versus Extended-Release Tolterodine: Results From the Overactive Bladder Innovative Therapy Trial
Keywords: تولوترودین; electric stimulation therapy; tibial nerve; tolterodine; urinary bladder; overactive; urinary incontinence; urgeFDA, Food and Drug Administration; GRA, global response assessment; OAB, overactive bladder; OAB-q, overactive bladder questionnaire; OrBIT, Ov
A process for the rapid removal of dialkylamino-substituents from aromatic rings. Application to the expedient synthesis of (R)-tolterodine
Keywords: تولوترودین; Reductive deamination; Organocatalysis; Enantioselective; Tolterodine;
Determination of tolterodine and its 5-hydroxymethyl metabolite in human plasma by hydrophilic interaction liquid chromatography–tandem mass spectrometry
Keywords: تولوترودین; Tolterodine; LC–MS/MS; HILIC; Pharmacokinetics
Is There a Synergistic Effect of Topical Oestrogens When Administered with Antimuscarinics in the Treatment of Symptomatic Detrusor Overactivity?
Keywords: تولوترودین; Antimuscarinics; Detrusor overactivity; Oestrogens; Overactive bladder; Tolterodine; Urinary incontinence
Transdermal delivery of tolterodine by O-acylmenthol: In vitro/in vivo correlation
Keywords: تولوترودین; Tolterodine; O-Acylmenthol; In vitro studies; In vivo studies; Transdermal delivery
Combined Effects of Behavioral Intervention and Tolterodine in Patients Dissatisfied With Overactive Bladder Medication
Keywords: تولوترودین; urinary bladder; overactive; health behavior; tolterodine; urinary incontinence; urge; combination therapyER, extended release; OAB, overactive bladder; UUI, urgency urinary incontinence
Impact of solifenacin on quality of life, medical care use, work productivity, and health utility in the elderly: An exploratory subgroup analysis
Keywords: تولوترودین; elderly; overactive bladder; quality of life; solifenacin; tolterodine; work productivity;
Tolterodine Treatment Improves Storage Symptoms Suggestive of Overactive Bladder in Men Treated With α-Blockers
Keywords: تولوترودین; α-blockers; Overactive bladder; Muscarinic antagonists; Tolterodine
Tolterodine Extended Release Attenuates Lower Urinary Tract Symptoms in Men With Benign Prostatic Hyperplasia
Keywords: تولوترودین; prostate; prostatic hyperplasia; tolterodine; urinary tract; urination disorders
Tolterodine does not affect memory assessed by passive-avoidance response test in mice
Keywords: تولوترودین; Tolterodine; Memory; Passive avoidance; (Mouse)
Effect of tolterodine on sleep structure modulated by CYP2D6 genotype
Keywords: تولوترودین; Tolterodine; CYP2D6; Anticholinergics; Sleep; REM sleep; Drug side effects
Tolterodine Immediate Release Improves Sexual Function in Women with Overactive Bladder
Keywords: تولوترودین; Overactive Bladder; Tolterodine; Sexual Function; Antimuscarinics;
Urinary Incontinence at Orgasm: Relation to Detrusor Overactivity and Treatment Efficacy
Keywords: تولوترودین; Antimuscarinics; Coital urinary incontinence; Detrusor overactivity; Orgasm; Overactive bladder; Sexuality; Tolterodine; Urinary incontinence
Effective Treatment of Neurogenic Detrusor Dysfunction by Combined High-Dosed Antimuscarinics without Increased Side-Effects
Keywords: تولوترودین; Detrusor-sphincter-dyssynergia; Neurogenic bladder; Muscarinic antagonists; Side-effects; Tolterodine; Trospium; Oxybutynin; Spinal cord injury
A Systematic Review and Meta-Analysis of Randomized Controlled Trials with Antimuscarinic Drugs for Overactive Bladder
Keywords: تولوترودین; Overactive bladder; Urgency frequency syndrome; Detrusor overactivity; Muscarinic receptor antagonist; Darifenacin; Emepronium; Fesoterodine; Oxybutynin; Propantheline; Propiverine; Solifenacin; Tolterodine; Trospium
Effect of antimuscarinic drugs used for overactive bladder on learning in a rat passive avoidance response test
Keywords: تولوترودین; Antimuscarinic drug; Darifenacin; Oxybutynin; Propiverine; Solifenacin; Tolterodine; Learning; Passive avoidance task
Efficacy of Combined Anticholinergic Treatment and Behavioral Modification as a First Line Treatment for Nonneurogenic and Nonanatomical Voiding Dysfunction in Children: A Randomized Controlled Trial
Keywords: تولوترودین; urination disorders; behavior therapy; cholinergic antagonists; tolterodine; pediatricsDVSS, dysfunctional voiding scoring system; UTI, urinary tract infection
Does Tolterodine Extended Release Affect the Bladder Electrical Perception Threshold? A Placebo Controlled, Double-Blind Study With 4 and 8 mg in Healthy Volunteers
Keywords: تولوترودین; bladder; urinary incontinence; electrical stimulation; sensory thresholds; tolterodine; BMI; body mass index; Cmax; maximum plasma level; EPT; electrical perception threshold; ER; extended release; EVES; endovesical electrical stimulation; IR; immediate r
Outcomes in Overactive Bladder Treatment: Patient Perception—A Key to Success
Keywords: تولوترودین; Overactive bladder; Patient-reported outcomes; Tolterodine
Long-Term Tolerability of Tolterodine Extended Release in Children 5–11 Years of Age: Results from a 12-Month, Open-Label Study
Keywords: تولوترودین; Children; Long-term treatment; Tolterodine; Urinary incontinence
Effects of antimuscarinics on voiding function after cerebral infarction in a rat model of overactive bladder
Keywords: تولوترودین; Cerebral infarction; Muscarinic; Micturition; Overactive bladder; Tolterodine; (Rat)
Treatment Outcomes in the STAR Study: A Subanalysis of Solifenacin 5 mg and Tolterodine ER 4 mg
Keywords: تولوترودین; Antimuscarinic; Solifenacin; Tolterodine; Overactive bladder
Efficacy and Tolerability of Tolterodine Extended Release in Male and Female Patients with Overactive Bladder
Keywords: تولوترودین; Frequency; Overactive bladder; Tolterodine; Urgency; Gender
The Evidence for Antimuscarinic Agents in Female Mixed Urinary Incontinence
Keywords: تولوترودین; Antimuscarinic agents; Overactive bladder syndrome (OAB); Solifenacin; Stress incontinence; Tolterodine
Daily Intravesical Instillation of 1 mg Nociceptin/Orphanin FQ for the Control of Neurogenic Detrusor Overactivity: A Multicenter, Placebo Controlled, Randomized Exploratory Study
Keywords: تولوترودین; bladder; neurogenic; urinary incontinence; neurons; afferent; nociceptin receptor; spinal cord injuries; BC; bladder capacity; BOT; botulinum toxin; CISC; clean intermittent self-catheterization; DO; detrusor overactivity; DOI; detrusor overactivity incon
Safety and Tolerability of Tolterodine for the Treatment of Overactive Bladder in Men With Bladder Outlet Obstruction
Keywords: تولوترودین; safety; tolterodine; urodynamicsBCI, Bladder Contractility Index; BMI, body mass index; BOO, bladder outlet obstruction; BOOI, Bladder Outlet Obstruction Index; BPE, benign prostatic enlargement; DO, detrusor overactivity; LUTS, lower urinary tract sympto
Characterization of muscarinic receptor binding and inhibition of salivation after oral administration of tolterodine in mice
Keywords: تولوترودین; Bladder; Submaxillary gland; Oral administration; Tolterodine; Oxybutynin; Muscarinic receptor binding; Salivation
Anticholinergic Drugs in Patients with Bladder Outlet Obstruction and Lower Urinary Tract Symptoms: A Systematic Review
Keywords: تولوترودین; α-Blockers; Anticholinergic drugs; Antimuscarinics; Benign prostatic hyperplasia; Bladder outlet obstruction; Darifenacin; LUTS; Overactive syndrome; Oxybutynin; Solifenacin; Tolterodine
A Shifted Paradigm for the Further Understanding, Evaluation, and Treatment of Lower Urinary Tract Symptoms in Men: Focus on the Bladder
Keywords: تولوترودین; Benign prostatic hyperplasia; Lower urinary tract symptoms; Overactive bladder; Antimuscarinics; Tolterodine
TOLTERODINE EXTENDED RELEASE ATTENUATES LOWER URINARY TRACT SYMPTOMS IN MEN WITH BENIGN PROSTATIC HYPERPLASIA
Keywords: تولوترودین; prostate; prostatic hyperplasia; tolterodine; urinary tract; urination disorders
Design, synthesis and activity of novel derivatives of Oxybutynin and Tolterodine
Keywords: تولوترودین; Selective muscarinic antagonists; Azabicyclohexane; Oxybutynin; Tolterodine
Propiverine versus Tolterodine: Efficacy and Tolerability in Patients with Overactive Bladder
Keywords: تولوترودین; Propiverine; Tolterodine; Overactive bladder; Quality of life;
Comparison of Symptom Severity and Treatment Response in Patients with Incontinent and Continent Overactive Bladder
Keywords: تولوترودین; Overactive bladder; Urgency; Frequency; Incontinence; Tolterodine;
A Comparison of the Efficacy and Tolerability of Solifenacin Succinate and Extended Release Tolterodine at Treating Overactive Bladder Syndrome: Results of the STAR Trial
Keywords: تولوترودین; Antimuscarinic; Solifenacin; Incontinence; Tolterodine; Overactive bladder; Urinary urgency;